生物标志物还能显示生物进程与疾病相关进展的变化，或者甚至是疾病进展中的危险。
Biomarkers can also reveal changes in a biological pathway that correlate with disease progression, or even the risk of disease progression.
这些生物标志物是否有可能用于危险分层系统呢？
And do they have potential to be involved in the risk stratification system?
分子生物标志物的应用有助于我们早期识别生物学效应和易感人群，从而有利于毒物危险度评估，同时可用于发病机理和防治效果研究。
Molecular biomarkers can be used in early detection of biological effect, susceptible population, risk assessment and research on mechanism, treatment and prevention in diseases.
应用推荐